|
|
|
Volumn 1, Issue 2, 2003, Pages 119-124
|
|
Bioavailability versus bioequivalence: the cyclosporine model.
a
a
RIZK HOSPITAL
(Lebanon)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
ARTICLE;
BIOAVAILABILITY;
BLOOD;
COMPARATIVE STUDY;
CYTOPLASM;
DRUG MONITORING;
GRAFT REJECTION;
HUMAN;
INCIDENCE;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
PHARMACOKINETICS;
RETROSPECTIVE STUDY;
ADULT;
BIOLOGICAL AVAILABILITY;
CYCLOSPORINE;
CYTOPLASM;
DRUG MONITORING;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
LYMPHOCYTES;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
THERAPEUTIC EQUIVALENCY;
|
|
EID: 20444458381
PISSN: 13040855
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
